Recall Register

Aurobindo Pharma Ltd.: FDA recalls

FDA enforcement events from 2012 to 2018; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Aurobindo Pharma Ltd. as the recalling firm in 3 events. The events have 3 product records. The recalls started from 2012 to 2018. All the events are drug recalls. By FDA enforcement events, Aurobindo Pharma Ltd. is number 1,113 of 1,628 firms that have a page. Events that Aurobindo Pharma Ltd. started: none in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

3 events, newest first.

Type and class

Aurobindo Pharma Ltd.: events for each product type
TypeEvents
Drug3
Aurobindo Pharma Ltd.: events in each class
ClassEvents
Class I1
Class II1
Class III1
Share of the events of the firm in Class I
33%
Share of all events on the register in Class I
18%
Events with the status Ongoing
0

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Aurobindo Pharma Ltd., by the year that the recall started. The largest year is 2018, with 2 events.

Official channels

Cite this page

Recall Register. Aurobindo Pharma Ltd.: FDA recalls. https://recallregister.com/firm/aurobindo-pharma-ltd/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
3 Nov 2026
State of the firm address
N/A, NJ

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Aurobindo Pharma Ltd. have?
Class I: 1 event. Class II: 1 event. Class III: 1 event. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Aurobindo Pharma Ltd.?
FDA event 79119, which the firm started on 2 Feb 2018. The first product in the record is: Metformin Hydrochloride Tablets, USP 1000 mg, 500-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit -VII (SEZ)) Mahabubnagar (Dt)_509302 India, NDC 65862-010-05.
How many FDA recalls of Aurobindo Pharma Ltd. have the status Ongoing?
No event has the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.